Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

In April 2023, 23andMe was targeted in a hack that exposed the personal data of 6.9 million customers. The company agreed to ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...